-
Recent advances in the delivery of acne therapeutics
Dr. Afsaneh Motamed-Khorasani Medical & Allied HealthcareAcne is the most common skin disorder in adolescents with a prevalence of 80-85 percent. The problem starts when the hair follicles become clogged by androgen-induced increased sebum production, dirt and dead skin cells.
-
Treating Hepatitis C: The big question no one is asking
Jason Poquette PharmaceuticalIf 2014 will be remembered for anything, pharmaceutically speaking, it will probably be for the impact of the new oral Hepatitis C (HCV) therapies that entered the market. It began at the tail end of 2013 when Gilead introduced their $1,000-per-pill HCV cure known as Sovaldi (sofosbuvir).
-
Are independent pharmacies really that profitable?
Jason Poquette PharmaceuticalEvery year I look forward to reading Dr. Adam Fein's analysis of the profitability of independent pharmacies in the U.S. He is a respected industry analyst and writes well-researched posts on his blog, Drug Channels, which covers a wide range of drug distribution topics.
-
Traveling with chronic illnesses, especially diabetes
Cynthia Sheppard Solomon PharmaceuticalWhether a patient has diabetes or some other chronic illness, being prepared can make a trip much more pleasant. For example, carrying a personal health record complete with lists of prescriptions, dietary supplements and other personal information can make a huge difference in how enjoyable a trip can be, should something surprising occur.
-
Global medical plastics device trends keep expanding
Don Rosato EngineeringThe medical device industry is making important contributions to advances in healthcare. The sector is characterized by a high level of innovation and intense competition. One of the interesting aspects of research and development within the medical devices field is the coupling of diverse biomedical and engineering disciplines.
-
Is $2.6 billion the real cost of drug development?
Mike Wokasch PharmaceuticalYou might see an article or news headline claiming that it now costs $2.6 billion to discover, develop and get a new drug to market. The pharmaceutical industry will make sure everyone becomes aware of this staggering cost number. After all, the high risk and high cost of research are the foundation for justifying high drug prices.
-
Automated drug-refill reminders increase adherence rates
Jennifer S. O'Reilly PharmaceuticalAutomated drug-refill reminders are everywhere from a phone call that reminds CVS patients to pick up their medications to texts sent to patients' smartphones from Wal-Mart Pharmacy. These reminders can literally be a life-saver when it comes to busy patients needing to remember to refill their medications.
-
What’s behind high generic drug prices?
Mike Wokasch PharmaceuticalSkyrocketing generic drug prices have gotten the attention of patients, insurance companies, healthcare providers and the media. So much so that it prompted a congressional hearing during which Sen. Bernie Sanders (I-Vt.) cited federal records that suggest prices for more than 1,200 generic medications increased an average of 448 percent between July 2013 and July 2014.
-
Why are pharmacists not reporting adverse drug events?
Jennifer S. O'Reilly PharmaceuticalReporting an adverse drug reaction helps the pharmacist, the drug company that manufactures the drug, and the patient. When pharmacists do not report these events, it can hamper issues of medication errors and do the patient more harm than good.
-
Researchers examining new paths to treat pain and inflammation
Dorothy L. Tengler PharmaceuticalPain of any type — whether acute or chronic — is the most frequent reason for physician consultation in the United States, prompting half of all Americans to seek medical care annually. Although separate conditions, pain and inflammation are nearly always associated with each other.
All Pharmaceutical Articles